Adriaan van der Meer

Dr. Adriaan van der Meer is a researcher in the Department of Gastroenterology & Hepatology at Erasmus MC, Netherlands. He is actively involved in clinical and epidemiological research focusing on cholestatic liver diseases, particularly primary biliary cholangitis (PBC), autoimmune hepatitis, and liver transplantation. His work is frequently published in top-tier hepatology journals and involves extensive collaboration with international networks such as ERN RARE-LIVER and the Global PBC Study Group.

His research interests center on disease burden, treatment response, quality of life, and long-term outcomes in autoimmune liver diseases. He has contributed to studies on liver stiffness dynamics, risk-based surveillance after HCV cure, and the economic impact of cholestatic conditions. His recent publications show a strong focus on real-world data and multicenter collaborations to improve patient outcomes.

The most recent articles reflect a trend toward personalized monitoring and risk stratification in chronic liver diseases, with emphasis on non-invasive biomarkers and patient-centered outcomes. His work bridges clinical practice and population-level insights.

Scientific Contributions:

• Active contributor to ERN RARE-LIVER and Global PBC Study Group
• Research on quality of life in autoimmune hepatitis
• Investigations into biochemical response and prognosis in PBC
• Editorials on hepatocellular carcinoma surveillance post-HCV cure

Dr. van der Meer has supervised doctoral research, indicating a role in mentoring junior scientists. While specific grants are not mentioned, his involvement in large multicenter studies suggests participation in funded collaborative projects. He is part of a robust research network with strong European and international ties, contributing to both clinical guidelines and epidemiological understanding of rare liver diseases.